Veterinary News and Research

RSS

Bio-Matrix Scientific Group's new opportunities in cancer treatment and intellectual property discussed

Bio-Matrix Scientific Group, Inc. Chairman & CEO David Koos commented on the Company’s new opportunities in stem cell research, cancer treatment and intellectual property.

1 Sep 2009

Banfield Veterinary Clinical Center Student Commons dedicated in honour of the Naimoli family by WesternU

WesternU celebrated the generous contributions of the Naimoli family with the dedication of the Banfield Veterinary Clinical Center Student Commons in their honor.

29 Aug 2009

H1N1 virus detected in turkeys

The detection of an H1N1 virus in turkeys in Chile raises concern that poultry farms elsewhere in the world could also become infected with the pandemic flu virus currently circulating in humans, FAO said today.

27 Aug 2009

BMSN and ENTB collaborate with Therinjectto to develop a new immuno-therapeutic cancer vaccine

Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.

27 Aug 2009

FDA releases consumer health information updates

The U.S. Food and Drug Administration today released its latest listing of consumer health information updates. All articles can be accessed from the agency's Web page for consumers. You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis. A Consumer Update RSS feed is also available.

27 Aug 2009

Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully submitted final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Cobroxin, an over-the-counter (OTC) treatment for stage 2 (moderate to severe) chronic pain.

25 Aug 2009

Sunwin management to discuss growth strategies at the 2009 Rodman & Renshaw Annual Global Investment Conference

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie stevia in China, will present at the Rodman & Renshaw Annual Global Investment Conference taking place at the New York Palace Hotel September 9-11 as part of the Asia Track program on September 10th at 8:45 AM.

21 Aug 2009

AETC Chicago launches 24/7 veterinary emergency care center

As of September 1, Chicago's approximately 1.6 million pets* will have access to 24-hour emergency medical attention - and ongoing hospitalization - should they fall victim to accident or illness. Located at 3927 W. Belmont, Animal Emergency & Treatment Center (AETC) is the only veterinary emergency and specialty center in the city to offer care at any hour of the day or night, 365 days a year.

21 Aug 2009

New book reveals information on the occurrence and spread of rabies in bats

Bat Rabies is intended for scientists and the general public. Dr. Constantine presents the material in a simple, straightforward manner that serves both audiences. The book, prepared by the U.S. Geological Survey National Wildlife Health Center, was published with the goal of increasing public understanding of rabies and the often misunderstood bat, and providing a balanced perspective on the risk of bat rabies to people.

21 Aug 2009

Patterson Companies records 6% year-on-year sales growth in first-quarter

Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson’s business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.

20 Aug 2009

Nanoviricides herpes study discussed on CBS News report

NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company’s nanoviricides™ anti-Herpes drug candidates.

12 Aug 2009

H3N2 influenza unlikely to spread between humans

Seeing animals up close is an integral part of experiencing the state and county fairs that take place around the country each summer and fall. And with good hygiene, Kansas State University veterinary experts say fair visitors shouldn't worry about contracting diseases from animals.

11 Aug 2009

Nanoviricides anti-herpes drug candidate reduces viral load by 99.99%

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.

10 Aug 2009

Novel approach for developing an AIDS vaccine

Researchers at the Yerkes National Primate Research Center, Emory University, believe conventional vaccine strategies should not be the only avenue explored in the development of an effective AIDS vaccine.

7 Aug 2009

SAGE to publish Veterinary Pathology

SAGE is pleased to announce that it will begin publishing Veterinary Pathology, a key international journal of natural and experimental disease, beginning in 2010.

6 Aug 2009

Iowa funds swine vaccine research

A grant from a state economic development fund will help Iowa State University researchers develop and evaluate a vaccine designed to protect swine from novel H1N1 and other strains of influenza.

5 Aug 2009

Scientists discover original source of malignant malaria

Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.

3 Aug 2009

Virulence of pandemic H1N1 virus analyzed

Laboratory studies at Kansas State University and the work of a K-State researcher are making headway in the effort to control the pandemic H1N1 virus.

31 Jul 2009

Spermatagonial stem cells can be directly converted into other cell types

Researchers have found a way to directly convert spermatogonial stem cells, the precursors of sperm cells, into tissues of the prostate, skin and uterus. Their approach, described this month in the journal Stem Cells, may prove to be an effective alternative to the medical use of embryonic stem cells.

28 Jul 2009

Discovery of potential treatment for spinal muscular atrophy

Spinal Muscular Atrophy is the second-leading cause of infant mortality in the world. Ravindra Singh, associate professor in biomedical sciences at Iowa State University's College of Veterinary Medicine, would like to see Spinal Muscular Atrophy lose its high ranking and even slide off the list altogether.

28 Jul 2009